Construction and application of health management program for male patients with oligoasthenospermia from the perspective of health ecology

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2500109065

Enrollment

Unknown

Registered

2025-09-11

Start date

2025-10-01

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oligoasthenospermia

Interventions

Control group:Routine care

Test group:Health management program for male patients with oligoasthenospermia from the perspective of health ecology

Eligibility

Sex/Gender

Male

Age

22 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1 : Males aged 22-40 years . 2 : In line with the WHO diagnostic criteria for infertility, the first diagnosis of mild to moderate oligoasthenospermia patients ( semen examination was 5 < sperm concentration < 15 × 10^6 / ml. Forward motile sperm 5 < PR < 32 % ) . 3 : Abnormal semen routine examination . 4 : Junior high school and above education level, can identify and understand Chinese, no communication barriers . 5 : Clear consciousness, no serious medical and surgical and mental illness history. 6 : Voluntary participation in the study and signing of informed consent.

Exclusion criteria

Exclusion criteria: 1 : People with other serious physical illnesses or drug dependence . 2 : Patients with mental disorders or recent psychological trauma. 3 : Severe oligozoospermia patients ( severe oligozoospermia is 0 < sperm concentration < 5 × 10^6/ ml ; severe asthenospermia ( PR < 5 % ) . 4 : Oligoasthenoteratozoospermia patients. 5 : Obstructive azoospermia patients. 6 : Patients with obstructive azoospermia or obstructive oligozoospermia due to organic obstruction of the reproductive tract caused by congenital ( absence or atresia of the vas deferens, etc. ) or acquired ( infection, trauma, surgery, etc. ) . 7 : Men with chromosomal abnormalities. 8 : Participate in other clinical drug trials or weight management intervention researchers.

Design outcomes

Primary

Measure	Time frame
Perceived Social Support Scale;Psychological Resilience Scale;	—

Secondary

Measure	Time frame
Fertility Quality of Life Questionnaire;General Self-Efficacy Scale;	—

Countries

China

Contacts

Public ContactYuying Yan

Women's Hospital School of Medicine Zhejiang University

yanyuying@zju.edu.cn+86 137 5088 2607

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026